Providence Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in Providence
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
Providence News
Providence centenarian reflects on how US has changed during her lifetime
Bennie Fleming, a World War II veteran and the first Black nurse to teach at Rhode Island Hospital, has spent her life in service.
Friday’s girls’ rewind: Cannon School makes statement in blowout of Providence Day
In a matchup of the two best 4A private schools in North Carolina, Cannon ran past Providence Day, plus compete coverage of Friday’s girls’ basketball action.
German biotech Repairon picks Providence for U.S. HQ
Frank Ahmann, co-founder of XM Therapeutics, has been tapped to lead Repairon USA. The German regenerative heart-tissue maker is setting up its U.S. headquarters in Providence. A German biotech ...
Providence Therapeutics Announces World-First Personalized Pediatric mRNA Cancer Vaccine Trial
Providence Therapeutics, a Canadian clinical-stage mRNA biotechnology company, is supporting a world-first clinical trial evaluating personalized mRNA cancer vaccines for children with advanced and ...